Methyl palmitate prevents CCl4-induced liver fibrosis

Journal of Applied Toxicology

Volumn 28, Issue 8, 2008, Pages 1021-1026

  Rodríguez Rivera, Adriana ^a   Galicia Moreno, Marina ^a   Reyes Gordillo, Karina ^a   Segovia, José ^a   Vergara, Paula ^a   Moreno, Mario G ^a   Shibayama, Mineko ^a   Tsutsumi, Víctor ^a   Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Carbon tetrachloride; Cirrhosis; Cytokines; Fibrosis; Inflammation; Kupffer cells; Liver injury; Methyl palmitate; Necrosis; TGF

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN; CYTOKINE; PALMITIC ACID METHYL ESTER; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; IMMUNOMODULATION; KUPFFER CELL; LIPID PEROXIDATION; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOTRANSFORMATION; BLOTTING, WESTERN; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; COLLAGEN; DOWN-REGULATION; HISTOCYTOCHEMISTRY; LIPID PEROXIDATION; LIVER CIRRHOSIS; MALE; NECROSIS; PALMITATES; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 55549119647     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1368     Document Type: Article

References (30)

1. Barón V, Muriel P. 1999. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim. Biophys. Acta 1472: 173-180.
2. Bataller R, Brenner DA. 2005. Liver fibrosis. J. Clin. Invest. 115: 209-218. DOI: 10.1172/JCI200524282.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248-254.
4. Cai P, Kaphalia BS, Ansari GAS. 2005. Methyl palmitate: inhibitor of phagocytosis in primary rat Kupffer cells. Toxicology 210: 197-204. DOI: 10.1016/j.tox.2005.02.001.
5. Chen ZT, Li SL, Cai EQ, Wu WL, Jin JS, Zhu B. 2003a. LPS induces pulmonary intravascular macrophages producing inflammatory mediators via activating NF-kappa-B. J. Cell Biochem. 89: 1206-1214. DOI: 10.1002/jcb.10590.
6. Chen LY, Zuraw BL, Zhao M, Liu FT, Huang S, Pan ZK. 2003b. Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-κB activation in human peripheral blood monocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 284: L607-L613. DOI: 10.1152/ajplung.00116.2002.
7. Cowper KW, Currin RT, Dawson TL, Lindert KA, Lemasters JJ, Thurman RG. 1990. A new method to monitor Kupffer cell function continuously in the perfused rat liver: dissociation of glycogenolysis from particle phagocytosis. Biochem. J. 266: 141-147.
8. Elsharkawy AM, Mann DA. 2007. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46: 590-597. DOI: 10.1002/hep.21802.
9. Fernández-Martínez E, Pérez-Álvarez V, Tsutsumi V, Shibayama M, Muriel P. 2006. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. Exp. Toxicol. Pathol. 58: 49-58. DOI: 10.1016/j.etp.2006.03.002.
10. Garcia-Tovar C, Perez A, Luna J, Mena R, Osorio B, Aleman V, Mondragón R, Momep D, Rendon A, Hernández JM. 2001. Biochemical and histochemical analysis of 71 kDa dystrophin isoform (dp 71f ) in rat brain. Acta Histochem. 103: 209-224.
11. Gunawardhana L, Mobley SA, Sipes IG. 1993. Modulation of 1,2-dichlorobenzene hepatotoxicity in the Fischer 344 rat by a scavenger of superoxide anions and an inhibitor of Kupffer cells. Toxicol. Appl. Pharmac. 119: 205-213.
12. 38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170: 6244-6249.
13. Marzi I, Cowper K, Takei Y, Lindert K, Lemasters JJ, Thurman RG. 1991. Methyl palmitate prevents Kupffer cell activation and improves survival after orthopic liver transplantation in the rat. Transplant. Int. 4: 215-220.
14. Meng X, Qiu B, Li X, Song X. 1992. The role of Kupffer cells in the development of hepatic dysfunction during sepsis. Chin. Med. J. 105: 34-38.
15. Muriel P. 1997. Peroxidation of lipids and liver damage. In Oxidants, Antioxidants and Free Radicals, Baskin SI, Salem H (eds). Taylor and Francis: Washington, DC; 237-257.
16. Muriel P. 2006. Role of nitric oxide in liver disorders. In Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights, Ali S, Mann D, Friedman SL (eds). Science Publishers: Enfield, NH; 115-131.
17. Muriel P. 2007a. Some experimental models of liver damage. In Hepatotoxicity: from Genomics to in Vitro and in Vivo Models, Sahu S (ed.). Wiley: Chichester; 119-137.
18. Muriel P. 2007b. Cytokines in liver diseases. In Hepatotoxicity: from Genomics to in Vitro and in Vivo Models, Sahu S (ed.). Wiley: Chichester; 371-389.
19. Muriel P, Deheza R. 2003. Fibrosis and glycogen stores depletion induced by prolonged biliary obstruction in the rat are ameliorated by metadoxine. Liver Int. 23: 262-268.
20. Okawa H, Ohmishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by the thiobarbituric acid reaction. Anal. Biochem. 95: 351-358.
21. Pérez-Severiano F, Escalante B, Vergara P, Rios C, Segovia J. 2002. Age-dependent changes in nitric oxide synthase activity and protein expression in striate of mice transgenic for the Huntington's disease mutation. Brain Res. 951: 36-42.
22. Ramadori G, Saile B. 2004. Portal tract fibrogenesis in the liver. Lab. Invest. 84: 153-159. DOI: 10.1038/labinvest.3700030.
23. Reitman S, Frankel S. 1957. A colorimetric method for determination of serum oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28: 56-63.
24. Rose ML, Germolec DR, Schoonhoven R, Thurman RG. 1997. Kupffer cells are casually responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18: 1453-1456.
25. Rose ML, Rusyn I, Bojes HK, Belyea J, Cattley RC, Thurman RG. 2000. Role of Kupffer cells and oxidants in signaling peroxisome proliferators-induced hepatocyte proliferation. Mutat. Res. 448: 179-192.
26. Rosen HR, Keeffe EB. 2000. Evaluation of abnormal liver enzymes, use of liver test, and the serology of viral hepatitis. In Liver Disease Diagnosis and Management, Bacon BR, Di Bisceglie AM (eds). Churchill: Philadelphia, PA; 24-35.
27. Sarkar S, Khan MF, Kaphalia BS, Ansari GAS. 2006. Methyl palmitate inhibits lipopolysaccharide-stimulated phagocytic activity of rat peritoneal macrophages. J. Biochem. Mol. Toxicol. 20: 302-308. DOI: 10.1002/jbt.20150.
28. Shek FW, Benyon RC. 2004. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur. J. Gastroenterol. Hepatol. 16: 123-126.
29. 4-induced liver injury. Adv. Exp. Med. Biol. 283: 489-497.
30. Villa P, Demetri MT, Meazza C, Sironi M, Gnocchi I, Ghezzi P. 1996. Effect of methyl palmitate on cytokine release, liver injury and survival in mice with sepsis. Eur. Cytokine Networks 7: 765-769.